Figueroa M - Search Results

1

Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.

Rodriguez-Valverde V, Sarabia JM, González-Gay MA, Figueroa M, Armona J, Blanco R, Fernández-Sueiro JL, Martínez-Taboada VM. Rodriguez-Valverde V, et al. Among authors: figueroa m. Am J Med. 1997 Apr;102(4):331-6. doi: 10.1016/s0002-9343(97)00117-4. Am J Med. 1997. PMID: 9217613

2

Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.

Martínez-Taboada VM, Blanco R, Armona J, Uriarte E, Figueroa M, Gonzalez-Gay MA, Rodriguez-Valverde V. Martínez-Taboada VM, et al. Among authors: figueroa m. Clin Rheumatol. 2000;19(1):73-5. doi: 10.1007/s100670050017. Clin Rheumatol. 2000. PMID: 10752506

3

[Giant cell arteritis. A study of 191 patients].

Armona J, Rodríguez-Valverde V, González-Gay MA, Figueroa M, Fernández-Sueiro JL, Blanco R, Martínez-Taboada V. Armona J, et al. Among authors: figueroa m. Med Clin (Barc). 1995 Dec 2;105(19):734-7. Med Clin (Barc). 1995. PMID: 8523954 Review. Spanish.

4

Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome.

González-Gay MA, Rodríguez-Valverde V, Blanco R, Fernández-Sueiro JL, Armona J, Figueroa M, Martínez-Taboada VM. González-Gay MA, et al. Among authors: figueroa m. Arch Intern Med. 1997 Feb 10;157(3):317-20. doi: 10.1001/archinte.1997.00440240081012. Arch Intern Med. 1997. PMID: 9040299

5

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G. Martínez-Taboada VM, et al. Among authors: figueroa m. Ann Rheum Dis. 2008 May;67(5):625-30. doi: 10.1136/ard.2007.082115. Epub 2007 Dec 17. Ann Rheum Dis. 2008. PMID: 18086726 Clinical Trial.

6

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.

González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. González-Gay MA, et al. Among authors: figueroa m. Arthritis Rheum. 1998 Aug;41(8):1497-504. doi: 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z. Arthritis Rheum. 1998. PMID: 9704651

7

Haematogenous vertebral osteomyelitis in the elderly.

Belzunegui J, Intxausti JJ, De Dios JR, Del Val N, Rodríguez Valverde V, González C, Queiro R, Figueroa M. Belzunegui J, et al. Among authors: figueroa m. Clin Rheumatol. 2000;19(5):344-7. doi: 10.1007/pl00011175. Clin Rheumatol. 2000. PMID: 11055821

8

Vertebral osteomyelitis in northern Spain. Report of 62 cases.

Belzunegui J, Del Val N, Intxausti JJ, De Dios JR, Queiro R, González C, Rodríguez-Valverde V, Figueroa M. Belzunegui J, et al. Among authors: figueroa m. Clin Exp Rheumatol. 1999 Jul-Aug;17(4):447-52. Clin Exp Rheumatol. 1999. PMID: 10464555

9

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M; BIOBADASER Group. Carmona L, et al. Among authors: figueroa m. Arthritis Rheum. 2005 Jun;52(6):1766-72. doi: 10.1002/art.21043. Arthritis Rheum. 2005. PMID: 15934089 Free article.

10

Clinical features and predictive factors in psoriatic arthritis-related uveitis.

Queiro R, Torre JC, Belzunegui J, González C, De Dios JR, Unanue F, Figueroa M. Queiro R, et al. Among authors: figueroa m. Semin Arthritis Rheum. 2002 Feb;31(4):264-70. doi: 10.1053/sarh.2002.28798. Semin Arthritis Rheum. 2002. PMID: 11836659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

776 results

Search Page